推薦產品
生物源
synthetic
等級
pharmaceutical primary standard
agency
EP Reference Standard
API 家族
famotidine
形狀
solid
包裝
pkg of 110 mg
製造商/商標名
EDQM
儲存條件
protect from light
應用
pharmaceutical (small molecule)
格式
neat
運輸包裝
ambient
儲存溫度
2-8°C
SMILES 字串
N\C(N)=N\c1nc(CSCCC(=N)NS(N)(=O)=O)cs1
InChI
1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)
InChI 密鑰
XUFQPHANEAPEMJ-UHFFFAOYSA-N
基因資訊
human ... HRH2(3274)
尋找類似的產品? 前往 產品比較指南
一般說明
Famotidine is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
應用
This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.
生化/生理作用
H2组胺受体拮抗剂;抗溃疡剂。
包裝
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
其他說明
Sales restrictions may apply.
相關產品
產品號碼
描述
訂價
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 2
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Famotidine
European pharmacopoeia, 29(1-2), 2609-2610 (2017)
Determination of famotidine in acid reduction tablets by HPTLC and videodensitometry of fluorescence quenched zones
Journal of Liquid Chromatography and Related Technologies, 26(16), 2719-2727 (2003)
Occupational allergic contact dermatitis from intermediate products in famotidine synthesis.
Contact dermatitis, 31(4), 259-260 (1994-10-01)
Clinical pharmacokinetics, 31(2), 103-110 (1996-08-01)
Famotidine, an H2 receptor antagonist, has several potential advantages over cimetidine and ranitidine. These advantages include its potency, relatively longer elimination half-life, and lack of interaction with the cytochrome P450 isoforms. Eight studies addressing the use of famotidine in paediatric
Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column
Journal of Separation Science, 31(2) (2008)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務